Skip to content

XOMA

XOMA Royalty Corp.

NASDAQ · Healthcare · Biotechnology · US

$40.17
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue36.2M52.1M28.5M4.8M6.0M
Cost of Revenue2.4M3.0M206.0K143.0K274.0K
Gross Profit33.8M49.2M28.3M4.6M5.8M
Operating Expenses
R&D Expense468.0K1.7M2.9M143.0K153.0K
SG&A Expense39.8M36.1M34.5M27.2M23.2M
General & Admin Expense39.8M36.1M34.5M25.6M23.2M
Selling & Marketing Expense(3.0K)1.6M
Other Expenses(11.4M)(11.0K)30.9M19.1M(177.0K)
Total Operating Expenses28.8M37.8M68.3M46.5M23.2M
Cost and Expenses31.3M40.8M68.5M46.6M23.4M
Operating Income (EBIT)5.0M11.4M(40.0M)(41.8M)(17.4M)
Non-Operating
Interest Income843.0K694.0K
Interest Expense12.9M13.0M13.8M569.0K
Net Interest Income(12.1M)(13.0M)(13.8M)(569.0K)694.0K
Other Non-Op Income/Expense28.9M20.4M20.5M1.0M295.0K
Non-Operating Income (excl Interest)(41.9M)(33.5M)(34.3M)(18.4M)(295.0K)
EBT (Pre-Tax Income)33.9M31.8M(19.5M)(40.8M)(17.1M)
Income Tax Expense104.0K103.0K(5.7M)(15.0K)
Bottom Line
Net Income31.5M31.7M(13.8M)(40.8M)(17.1M)
Earnings from Cont. Ops33.8M31.7M(13.8M)(40.8M)(17.1M)
Earnings from Discont. Ops
Bottom Line Net Income28.2M26.2M(19.3M)(46.3M)(22.6M)
Per Share
Basic EPS$1.65$1.53($1.65)($4.04)($1.98)
Diluted EPS$1.57$1.46($1.65)($4.04)($1.98)
Revenue Per Share$3.05$2.90$2.43$0.41$0.53
Shares
Basic Shares Outstanding11.9M18.0M11.7M11.5M11.4M
Diluted Shares Outstanding17.4M18.0M11.7M11.5M11.4M
Profitability Metrics
EBITDA50.2M47.8M(5.4M)(22.6M)(16.8M)
D&A3.3M3.0M216.0K900.0K274.0K
EBIT46.8M44.8M(5.6M)(23.5M)(17.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026